Goldline Pharmaceutical Limited (BOM:544759)
India flag India · Delayed Price · Currency is INR
29.60
+0.33 (1.13%)
At close: Nov 16, 2026

Goldline Pharmaceutical Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
-311.98280.56235.66198.48240.11
Other Revenue
-0----
-311.98280.56235.66198.48240.11
Revenue Growth
-11.20%19.05%18.73%-17.34%9.66%
Cost of Revenue
-112.19108.3960.8658.5154.02
Gross Profit
-199.79172.16174.8139.9986.08
Selling, General & Admin
-71.3357.8458.0456.3354.41
Other Operating Expenses
-57.7552.8573.359.5214.63
Operating Expenses
-131.5113.2132.98117.669.54
Operating Income
-68.2958.9741.8222.3916.54
Interest Expense
--14.07-18.48-14.78-15.35-12.11
Interest & Investment Income
-0.01---0.07
Other Non Operating Income (Expenses)
--0.38-0.99-1.35-0.98-
EBT Excluding Unusual Items
-53.8539.525.696.054.5
Gain (Loss) on Sale of Assets
---0.91-0.42-2.04-
Pretax Income
-53.8538.5825.274.014.5
Income Tax Expense
-12.6810.247.211.451.19
Net Income
-41.1728.3418.062.573.32
Net Income to Common
-41.1728.3418.062.573.32
Net Income Growth
-45.26%56.94%603.82%-22.64%60.38%
Shares Outstanding (Basic)
977666
Shares Outstanding (Diluted)
977666
Shares Change
--14.95%0.04%0.09%-0.49%
EPS (Basic)
-5.974.113.010.430.55
EPS (Diluted)
-5.974.113.010.430.55
EPS Growth
-45.26%36.52%603.53%-22.71%61.17%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-27.5829.7418.1412.83-
Free Cash Flow Per Share
-4.004.313.022.14-
Gross Margin
-64.04%61.37%74.17%70.53%35.85%
Operating Margin
-21.89%21.02%17.75%11.28%6.89%
Profit Margin
-13.20%10.10%7.66%1.29%1.38%
Free Cash Flow Margin
-8.84%10.60%7.70%6.46%-
EBITDA
-70.761.4743.4624.1417.05
EBITDA Margin
-22.66%21.91%18.44%12.16%7.10%
D&A For EBITDA
-2.412.51.641.750.51
EBIT
-68.2958.9741.8222.3916.54
EBIT Margin
-21.89%21.02%17.75%11.28%6.89%
Effective Tax Rate
-23.55%26.54%28.53%36.06%26.34%
Revenue as Reported
-311.99280.56235.66198.49240.18
Advertising Expenses
-0.630.31.711.590.6